SNAI1 and breast carcinoma: For example, in basal-like breast cancer, SNAI1 represses fructose-1,6-bisphophatase 1 (FBP1), promoting glucose uptake and the diversion of glycolytic carbons towards biosynthetic pathways, including the pentose phosphate pathway (PPP), and impairing the activity of the respiratory chain complex I [15].